General Surgery Department, North China University of Science and Technology Affiliated Hospital, Tangshan City, China.
Intensive Care Unit, North China University of Science and Technology Affiliated Hospital, Tangshan City, China.
Medicine (Baltimore). 2023 Sep 29;102(39):e35422. doi: 10.1097/MD.0000000000035422.
MicroRNA-142-3p (miR-142-3p) has been reported to be implicated in colon cancer; however, the possible regulatory mechanisms and molecular subtypes regulated by miR-142-3p have not been fully elucidated. This study aimed to investigate the biological functions and regulatory mechanism of miR-142-3p in colon cancer. The expression level of miR-142-3p in colon cancer was analyzed based on the mRNA and miRNA expression datasets of colon cancer retrieved from The Cancer Genome Atlas. Target genes of miR-142-3p were also predicted. Based on these target genes, the functions and subtypes of miR-142-3p were investigated. The metabolic and tumor-related pathways, immune microenvironment, and target gene expression between the 2 subtypes were analyzed. MiR-142-3p was upregulated in tumor tissues, and its high expression indicated a poor prognosis. A total of 39 target genes were predicted, which were significantly involved in autophagy- and metabolism-related functions and pathways. Based on these target genes, the colon cancer samples were clustered into 2 subtypes. There were 35 metabolism-related pathways that were significantly different between the 2 clusters. The immune and stromal scores in cluster 2 were higher than those in cluster 1, whereas the tumor purity of cluster 2 was significantly lower than that of cluster 1. TP53INP2 expression in cluster 2 was higher than that in cluster 1. MiR-142-3p may promote colon cancer progression via autophagy- and metabolism-related pathways. MiR-142-3p may be served as a candidate target for the treatment of colon cancer.
microRNA-142-3p(miR-142-3p)已被报道与结肠癌有关;然而,miR-142-3p 调节的可能调控机制和分子亚型尚未完全阐明。本研究旨在探讨 miR-142-3p 在结肠癌中的生物学功能和调控机制。基于从癌症基因组图谱中检索到的结肠癌 mRNA 和 miRNA 表达数据集,分析了结肠癌中 miR-142-3p 的表达水平。还预测了 miR-142-3p 的靶基因。基于这些靶基因,研究了 miR-142-3p 的功能和亚型。分析了 2 个亚型之间的代谢和肿瘤相关途径、免疫微环境和靶基因表达。miR-142-3p 在肿瘤组织中上调,其高表达表明预后不良。共预测到 39 个靶基因,这些靶基因显著参与自噬和代谢相关功能和途径。基于这些靶基因,将结肠癌样本聚类为 2 个亚型。在这 2 个簇之间有 35 个代谢相关途径存在显著差异。簇 2 的免疫和基质评分高于簇 1,而簇 2 的肿瘤纯度明显低于簇 1。簇 2 中的 TP53INP2 表达高于簇 1。miR-142-3p 可能通过自噬和代谢相关途径促进结肠癌的进展。miR-142-3p 可能作为结肠癌治疗的候选靶点。